In vitro diagnostic kit for detecting KRAS gene mutations in patient samples. Enables rapid molecular identification of KRAS mutations for oncology treatment planning and patient stratification. Supports precision medicine approaches in cancer care.
Manufactured by
HymonBio Co., Ltd.
Suzhou, Jiangsu, China
HymonBio Co., Ltd. was established in 2015, with co-founder from the Chinese Academy of Sciences. The company focuses on the development, production, and sale of precision-medicine and point-of-care (POCT) related products. Since its establishment in Taicang BIOBAY, HymonBio has applied for 36 patents and obtained 16 authorized patents; 11 products have obtained Chinese medical device certificates; 59 products have obtained CE certificates; 1 product has obtained an FDA certificate and passed the ISO13485 system certificate. The company has won awards such as high-tech enterprises, private technology enterprises in Jiangsu Province, enterprises supported by the Double Innovation Plan of Jiangsu Province, and Suzhou Female Innovation and Entrepreneurship Leading Talent Enterprises. Most recently, HymonBio has completed the first round of financing, which is also the first overseas investment project of PerkinElmer Ventures, a leading company in the IVD industry, in China.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Shanghai Devulon Material Co.,Ltd
China · 1 relevant product
TRUPCR Europe Ltd
United Kingdom · 12 relevant products
PlexBio Co., Ltd.
Taiwan · 4 relevant products
51 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →11 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 106 closest product alternatives
Shanghai Devulon Material Co.,Ltd · China
A companion diagnostic test kit designed for detecting KRAS mutations in cancer samples. This kit is used in conjunction with specific therapeutic treatments for patients with companion diagnostic indications. The kit includes quality control materials and has been validated for clinical use in tumor sample analysis.
TRUPCR Europe Ltd · United Kingdom
A real-time PCR diagnostic kit for KRAS mutation detection. Applied in solid tumour diagnostics for identifying KRAS gene mutations associated with various cancer types.
PlexBio Co., Ltd. · Taiwan
A qualitative diagnostic test for the detection of 27 somatic mutations in the KRAS gene. This kit is used for oncology molecular profiling and mutation analysis in cancer diagnostics.
103 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products